RUNX1/ETO-IN-1
RUNX1/ETO-IN-1 is an inhibitor targeting the oncogenic fusion protein RUNX1-ETO, specifically affecting the NHR2 oligomerization domain. It binds directly to NHR2 (KD, app = 39 μM) . By inducing apoptosis and promoting differentiation, RUNX1/ETO-IN-1 exhibits antileukemic activity in RUNX1/ETO translocation acute myeloid leukemia (AML) cells. Its near-neutral charge under physiological pH conditions grants it excellent cell membrane permeability.
Product Specifications
CAS Number
923865-06-9
Field of Research
Cancer Biology, Cell Biology
Smiles
O=C1C=C (N=C2SC=C (N12) C) CNC (C3=CC=C4OCCCOC4=C3) C (C) C
Molecular Formula
C21H25N3O3S
Molecular Weight
399.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PO54986E1 100 µg
SARS-CoV-2 (2019-nCoV) envelope (CoV-E) protein (C40A, C43A, C44A) -His & MBP Recombinant Protein
Sign In for Pricing
View Details 